TAG:
near-patient testing
Truvian Sciences Raises $105M for Near-Patient Lab Test System
By Robert Michel | From the Volume XXVIII, No. 4 – March 22, 2021 Issue
DESPITE THE PANDEMIC, investors continue to support emerging in vitro diagnostics (IVD) companies. This is particularly true of start-up companies that want to develop clinical lab testing systems that can be used at the point of care, that require small amounts of blood, and that deliver accu…
NEWSMAKER INTERVIEW: Ralph Taylor, CEO of Sysmex America
By R. Lewis Dark | From the Volume XXV No. 3 – February 12, 2018 Issue
“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures. Core laboratories have something unique and irreplacea…
Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry
By Joseph Burns | From the Volume XXV No. 3 – February 12, 2018 Issue
“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures.” …
FDA CLEARS WAIVED CBC FOR NEAR-PATIENT TESTING
By R. Lewis Dark | From the Volume XXIV No. 16 – November 20, 2017 Issue
CEO SUMMARY: Market clearance of the first-ever CLIA waived analyzer for complete blood count and three-part differential tests could cut time-to-answer from days to mere minutes for one of the top 20 tests by volume performed at core laboratories. Developer …
Docs’ In-Office Testing Showing Mixed Trends
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
CEO SUMMARY: Despite the burdens of CLIA certification and reduced reimbursement for lab tests, many medical practice experts are advising doctors to expand in-office testing. However, diagnostic technologies for near-patient testing are still not robust enough to support this trend. Earl…
Nurse Shortage Parallels That of Fewer Med Techs
By Robert Michel | From the Volume VIII No. 3 – February 26, 2001 Issue
CEO SUMMARY: It’s a story that will soon become a national headline. Even as laboratories struggle to find enough med techs to fill open positions, hospitals are facing an even bigger problem in getting enough nurses to keep units staffed and open. Recruiting nurses overseas is one solu…
Management Execution Makes a Difference
By R. Lewis Dark | From the Volume VII No. 14 – October 2, 2000 Issue
THERE’S PLENTY OF HOOROAR AND EXCITEMENT about skyrocketing stock prices for several public lab and pathology companies in 2000! But this crusty old curmudgeon has been around the investment industry too long to accept Wall Street’s new-found enthusiasm for clinical laboratories as definitive pr…
Qualigen’s POL PSA Test Cleared for Sale by FDA
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPack™ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
“State of Lab Industry” Reveals Radical Change
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
CEO SUMMARY: Pick your trend: declining reimbursement, consolidation, clinical integration, downsizing, and capitated reimbursement. These trends all continued to shape the way laboratories organized to provide services. But 1997’s wildcard was the federal government. Between investigat…
Joint Venture In Phoenix To Be Copied Elsewhere
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…
CURRENT ISSUE

Volume XXX, No. 13 – September 11, 2023
Recent court rulings involving the No Surprises Act are putting the government on the defensive about provisions of the law. Also, the continued consolidation of the IVD and national laboratory company markets has brought more influence to those lab companies. In addition, learn how clinical labs can earn money from their diagnostic data by helping private insurers navigate Medicare Advantage’s risk adjustment model.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com
© 2022 The Dark Report. All rights reserved.